Lexaria Bioscience Corp. - Director's Dealing 2009

SEC Form 4/A — Form 4/A

Issuer: LEXARIA CORP. (LXRP)
CIK: 0001348362
Period of Report: 2009-07-28

Reporting Person: BUNKA CHRISTOPHER (Director, Chairman/CEO/President, 10% Owner)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2009-07-10	Common Shares	P	1600000	$0.05	Acquired	1988213	Indirect

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2009-07-10	Warrants	$0.2	P	1600000	Acquired	2011-07-10	Common Shares (1600000)	Indirect
2009-07-08	Stock Options	$0.2	P	18750	Acquired	2011-07-08	Common Shares (18750)	Direct

Security	Shares	Ownership
Common Shares	215900	Direct

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Warrants	$2.4	2009-11-09	Common Shares (291700)	291700	Indirect
Stock Options	$0.2	2011-04-26	Common Shares (100000)	100000	Direct
Stock Options	$0.2	2011-07-20	Common Shares (100000)	100000	Direct
Convertible Debt	$0.05	2009-10-27	Common Shares (43333)	43333	Direct
Convertible Debt	$0.05	2010-10-27	Common Shares (43333)	43333	Direct
Convertible Debt	$0.05	2009-10-27	Common Shares (32500)	32500	Indirect
Convertible Debt	$0.05	2010-10-27	Common Shares (32500)	32500	Indirect

F1: Chris Bunka is the sole owner of CAB Financial Services Ltd.

F2: On July 8, 2009, the exercise price was reduced from $0.80; post share consolidation price was $3.20.

F3: On July 8, 2009, the exercise price was changed from $0.12; post share consolidation price was $0.48.

F4: On July 9, 2009, the exercise price was changed from $0.45.